# FDA Inspection 1251663 - Rashmi Singh, M.D. - August 02, 2024

Source: https://www.keypedia.com/records/fda_inspections/rashmi-singh-md/02626578-5909-45f6-a371-433a8ec2e17b
Source feed: FDA_Inspections

> FDA Inspection 1251663 for Rashmi Singh, M.D. on August 02, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1251663
- Company Name: Rashmi Singh, M.D.
- Inspection Date: 2024-08-02
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/rashmi-singh-md/d64a0b45-0251-433e-94e3-e0c0af1bfbe6

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c